Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study

被引：0
|
作者：
David M Kern
Jill Davis
Setareh A Williams
Ozgur Tunceli
Bingcao Wu
Sally Hollis
Charlie Strange
Frank Trudo
机构：
[1] HealthCore,Department of Medicine, Division of Pulmonary and Critical Care Medicine
[2] Inc.,undefined
[3] AstraZeneca Pharmaceuticals,undefined
[4] AstraZeneca Pharmaceuticals,undefined
[5] AstraZeneca Pharmaceuticals,undefined
[6] Medical University of South Carolina,undefined
来源：
Respiratory Research | / 16卷
关键词：
Chronic obstructive pulmonary disease (COPD); Inhaled corticosteroid/long-acting β; -agonist combinations (ICS/LABA); Comparative effectiveness; Controller treatments; Administrative claims;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for chronic obstructive pulmonary disease: Possible confounding effect of treatment withdrawal?
    Brown, Samuel M.
    ANNALS OF INTERNAL MEDICINE, 2007, 147 (12) : 882 - 882
  • [22] Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
    Shang, Nan
    Liu, Yang
    Jin, Yueping
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 21 (01)
  • [23] Evaluation of a Therapeutic Interchange from Fluticasone/Salmeterol to Mometasone/Formoterol in Patients with Chronic Obstructive Pulmonary Disease
    Yip, Elaine
    Karimi, Sahar
    Pien, Linda T.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (04): : 316 - 323
  • [24] Evaluation of a therapeutic interchange from fluticasone/salmeterol to mometasone/formoterol in patients with chronic obstructive pulmonary disease
    Yip, Elaine
    Karimi, Sahar
    Pien, Linda
    PHARMACOTHERAPY, 2014, 34 (06): : E114 - E115
  • [25] Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease
    Dalal, Anand A.
    Roberts, Melissa H.
    Petersen, Hans V.
    Blanchette, Christopher M.
    Mapel, Douglas W.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 6 : 13 - 22
  • [26] Combination of Fluticasone Furoate and Vilanterol for the Treatment of Chronic Obstructive Pulmonary Disease
    Bollmeier, Suzanne G.
    Prosser, Theresa R.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (02) : 250 - 257
  • [27] The surprising results of the inhaled combination budesonide/formoterol in patients with chronic obstructive respiratory disease
    Popescu, L. Livia
    Balan, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 114 - 114
  • [28] Effectiveness of Budesonide/Glycopyrrolate/Formoterol Fumarate in Chinese Patients With Chronic Obstructive Pulmonary Disease
    Sun, Y.
    Chen, Y.
    Zhou, L.
    Zhang, X.
    Guo, R.
    Feng, J.
    Xiong, X.
    Li, G.
    Xu, W.
    Zhang, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
    Jayanthi, Nalini
    Krishnan, Karthickeyan
    Sudhir, Manali
    Girija, S.
    Nishi, P. A.
    Kumar, J. Sathish
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 28
  • [30] Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
    Matera, Maria Gabriella
    Sanduzzi, Alessandro
    Cazzola, Mario
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 73 - 79
12345